Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 30th May 2024
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Enzootic abortion vaccine supply issues announced
Ceva Animal Health says it is treating the issue with the “utmost urgency”.
Supply gap to affect UK this summer.

Ceva Animal Health has announced that there will be a gap in the supply of its enzootic abortion of ewes (EAE) vaccine Cevac Chlamydia between June and August.

The company has said the issue has been caused by a batch failure during the manufacturing process and that it deeply regrets any inconvenience caused.

Last year also saw a shortage of the vaccine in the UK, which Ceva Animal Health blamed on delays in the manufacturing and distribution process. The issue was resolved by September and the company again hopes that the vaccine will become available later in the year.

Roy Geary, Ceva Animal Health’s regional director for Northern Europe, said: “Our dedicated team is working closely with our partners to resolve the challenges and restore normal supply levels as soon as possible. The vaccine challenge is being treated with the utmost urgency, and we are actively exploring alternative options to speed up the supply chain for future batches of the vaccine.

“We anticipate that the issue in supply will be resolved, with some stock potentially available later in the season, however we recognise that for some farmers the supply will arrive too late for them to use.”

Until the vaccine becomes available again, Ceva Animal Health has recommended that veterinary surgeons look at alternative ways to help their clients protect their flocks.

Mr Geary added: “We are encouraging vets to explore alternative means of safeguarding the health of their clients’ flocks during this period. We recommend implementing robust biosecurity measures and adhering to existing vaccination protocols for other preventable diseases to ensure the overall wellbeing of livestock.

“We will provide vet practices and the wider industry with regular updates as we progress toward a resolution and return to normal supply levels.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.